TopAbstracts in Influenza 07/03/2008 TopAbstracts in Influenza are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 28 days.Over 2000 peer-reviewed...
Beckman Coulter gets rights to HCV viral load test Beckman Coulter UK has acquired the rights from Siemens Healthcare Diagnostics to allow it to develop, manufacture and sell a quantitative viral load HCV blood test for use on the molecular diagnostic instrument it is currently developing.
Call for mass child hepatitis B jab Children should be vaccinated against hepatitis to prevent the spread of medicine-resistant strains of the disease, according to a report published by The Association of The British Pharmaceutical Industry (ABPI).Strains of ...
Stem cells from umbilical cord used in the treatment of hepatic diseases Scientists of the University of Granada, in collaboration with the University of Len, have confirmed that stem cells from human umbilical cord blood can be an appropriate therapy for the treatment of hepatic diseases such as ...
New hepatitis C virus vaccines study findings reported from Research Center for Infectious Diseases - (NewsRx.com) -- Fresh data on hepatitis C virus are presented in the report 'Open-label trial of therapeutic immunization with oral V-5 Immunitor (V5) vaccine in patients with chronic hepatitis C.New hepatitis C virus...
SOLVO is the exclusive commercial provider of B-CLEAR kits and a provider of B-CLEAR services in Europe June 13th 2008: Qualyst, Inc.s patented B-CLEAR sandwich-cultured hepatocyte technology is the only in vitro method which can evaluate hepatobiliary disposition of a compound, predict in vivo hepatic uptake and biliary clearance, and...
Trophos appoints Damian Marron as Chief Executive Officer Marseille, June 12th, 2008 - Trophos SA, a biopharmaceutical company specializing in the discovery and development of drugs for neurological disorders, announced today the appointment of Damian Marron as Chief Executive Officer, effective...
Peregrine Pharmaceuticals awarded DTRA contract worth up to $44.4 million to develop Bavituximab for Viral Hem TUSTIN, Calif.- Peregrine Pharmaceuticals, Inc.
(NASDAQ:PPHM) , a clinical stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer and hepatitis C virus (HCV) infection, today announced it has...
Blood Components ABS is skilled in isolating purified blood cell populations, blood platelets, blood proteins, and blood fractions from human and animal blood.For example, we routinely prepare: neutrophils eosinophils platelets plasma red blood cells...
Hot paper in Gene Expression: Caution: RNAi Biophoto Associates / Photo Researchers, Inc.Grimm et al., 'Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways,' Nature, 441:537-41, 2006.
(Cited in 147 papers) While studying the potential of RNA...
Key Challenges and Issues facing the World Immunoassay Instruments Market IMMUNOASSAY INSTRUMENTS MCP-3522 A GLOBAL STRATEGIC BUSINESS REPORT CONTENTS I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS Study Reliability and Reporting Limitations I-1 Disclaimers I-2 Data Interpretation & Reporting...
Entecavir therapy for lamivudine-refractory chronic hepatitis B: Improved virologic, biochemical, and serology Hepatitis B Articles (HBV) Back  Entecavir therapy for lamivudine-refractory chronic hepatitis B: Improved virologic, biochemical, and serology outcomes through 96 weeks Hepatology July 1, 2008 Morris Sherman 1 *, Cihan...
TopAbstracts in Cirrhosis 07/01/2008 TopAbstracts in Cirrhosis are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 28 days.Over 2000 peer-reviewed...
Hepatic Cancer - Recent findings in hepatic cancer described by researchers from Akita University, Department A report, 'Tumor-liver contrast and subjective conspicuity of respiratory-triggered T2-weighted fast spin-echo sequence compared with T2*-weighted gradient recalled-echo sequence for ferucarbotran-enhanced of tumors,' is newly published data...
Pharmasset Joins Russell 3000 Index PRINCETON, N.J.Pharmasset's membership in the Russell 3000, which remains in place for one year, means automatic inclusion in the small-cap Russell 2000(R) Index as well as the appropriate growth and value style indexes.
Russell indexes...
Novelos Therapeutics Receives 6th U.S. Patent - Novelos Therapeutics, Inc.(OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that Novelos was issued U.S.
7,371,411 by the U.S.
Patent and...
Pharmasset Joins Russell 3000 Index PRINCETON, N.J., July 1 /PRNewswire-FirstCall/ -- Pharmasset, Inc.joined the broad-market Russell 3000(R) Index when Russell Investments reconstituted its equity indexes on June 27.
Pharmasset's membership in the Russell 3000, which...
Children Must Be Protected Against Hepatitis, Warns ABPI _ Children Must Be Protected Against Hepatitis, Warns ABPI.
Transition Therapeutics Inc - Premium Company Profile - New Research Report on Companies and Markets Company-Profile/Transition-T ..Introduction Transition Therapeutics is a biopharmaceutical company, developing novel therapeutics for disease indications with large markets.
The company's patented drug discovery technologies have helped...
Cubist Pharmaceuticals to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V Cubist Pharmaceuticals, Inc.(CBST) today announced that it has signed an exclusive agreement with AstraZeneca (AZN) to promote and provide other support in the United States for MERREM I.V.
(meropenem for injection), an established...
Cubist Pharmaceuticals to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V Leverages Proven U.S.Acute Care Sales Organization Complements Cubists Gram-Positive CUBICIN Company Website: http://www.cubist.com LEXINGTON, Mass.
-- (Business Wire) Cubist Pharmaceuticals, Inc.
(NASDAQ: CBST) today announced that...
Pediatric Chest Pain: Keys to the Diagnosis Children's Hospital of Michigan, Texas Children's Hospital, Children's Hospital of Michigan, and Wayne State University Dr Kundra is a fellow in the department of pediatrics and emergency medicine at Children's Hospital of Michigan in...
Important FDA Label changes to Viramune (nevirapine) oral solution and tablets FDA approved labeling changes to the Viramune (nevirapine) oral solution and tablets to reflect various updates, including: - Dosing recommendations for pediatric patients 15 days to 2 months of age.- Dose recommendations for all...
Early Results from Ongoing Clinical Study of Hepatitis C Vaccine Delivered by Inovio Biomedical's Electroporat - Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced today that its partner, Tripep AB, reported additional interim results from its ongoing...
Journal of Clinical Oncology Publishes Leukine(R) Study Demonstrating Positive Survival Outcomes in Patients w - Phase II Trial Shows Increase in Mature Dendritic Cells - WAYNE, N.J., June 30 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals today confirmed that results of a Phase II trial were published in the July 1 edition of the Journal...
